siRNA, Anti-S100A2, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT21048WQ-2OMe)

The product SIRGT21048WQ-2OMe is a type of small interfering RNA (siRNA) that targets S100A2 gene and regulates the expression of gene. The siRNA interferes with the expression of S100A2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_005978.3
Alternative Names CAN19; S100L
Related Diseases Breast cancer, Conjunctival Intraepithelial Neoplasm
Purification HPLC
Target Gene
Gene ID 6273
Uniprot ID P29034
Sub Cat Target Species Modification Scale  
SIRGT22048WQ-2F S100A2 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT23048WQ-2MOE S100A2 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT24048WQ-LNA S100A2 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT21048WQ-RB S100A2 Human Ribo-modified Inquiry
SIRGT22048WQ-BB S100A2 Human Backbone-modified Inquiry

Related Products